Jennifer M Knight-Madden

7PUBLICATIONS
22CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)HaematologyAboriginal and Torres Strait Islander historyNeonatology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|May 26, 2025
Lentiviral gene therapy with reduced-intensity conditioning for sickle cell disease: a phase 1/2 trial.

Michael Grimley, Stella M Davies, Archana Shrestha

|Jul 22, 2021
Hydroxycarbamide treatment reduces transcranial Doppler velocity in the absence of transfusion support in children with sickle cell anaemia, elevated transcranial Doppler velocity, and cerebral vasculopathy: the EXTEND trial.

Angela Rankine-Mullings, Marvin Reid, Deanne Soares

|Oct 19, 2020
Newborn Screening for Sickle Cell Disease in the Caribbean: An Update of the Present Situation and of the Disease Prevalence.

Jennifer Knight-Madden, Ketty Lee, Gisèle Elana

|Mar 06, 2018
Transcranial Doppler velocity among Jamaican children with sickle cell anaemia: determining the significance of haematological values and nutrition.

Angela E Rankine-Mullings, Nadine Morrison-Levy, Deanne Soares

|Mar 02, 2018
Causes of death and early life determinants of survival in homozygous sickle cell disease: The Jamaican cohort study from birth.

Graham R Serjeant, Nicki Chin, Monika R Asnani

|Sep 14, 2016
EXpanding Treatment for Existing Neurological Disease (EXTEND): An Open-Label Phase II Clinical Trial of Hydroxyurea Treatment in Sickle Cell Anemia.

Angela E Rankine-Mullings, Courtney R Little, Marvin E Reid

Pageof 2

Frequent Collaborators

3 joint publications

Angela Rankine-Mullings

2 joint publications

Monika Asnani

1 joint publications

Narcisse Elenga

1 joint publications

Beatriz Marcheco-Teruel